We’re looking forward to attending the American Society of Spine Radiology (ASSR) 2026 Annual Meeting, February 26-28, in New Orleans, LA.
As we expand into the U.S. market, this event is a key opportunity to engage with industry leaders and clinical professionals in the spine community. We’re excited to exchange insights and advance spine care together. Our CTO, Mo Ahmadi, PhD, will be on-site at the ASSR 2026 Annual Meeting to share insights on the VCFix® Spinal System, our solution for vertebral compression fractures.
Attending the ASSR 2026? Reach out to Mo Ahmadi, PhD to schedule a conversation or demo.
About Amber Implants
Amber Implants is now a commercial stage company, preparing for its US launch in 2026. Supported by strong worldwide patent protection and a growing product pipeline, the Company is on track to capture a significant share of the global €2 billion+ vertebral compression fracture market by 2029. FDA clearance of the VCFix® Spinal System not only accelerates adoption and revenue growth but also serves as a gateway for entry into additional global markets where FDA approval is recognized.
